"Hamlet Pharma is proud to announce the successful outcome of the Phase I/II trial, aimed at studying the safety and efficacy of Alpha1H in patients with bladder cancer. "

"highly significant differences between the Alpha1H treated patients and the placebo group, for several crucial efficacy variables. Treatment was also shown to be safe, as no drug-related side effects were observed."

https://www.spotlightstockmarket.com/sv/market-overview/nyheter//nyhets-artikel?id=52176

http://hamletpharma.com

https://forum.hegnar.no/thread/8716/view